More articles from 96. Bronchodilators in asthma and COPD

Doxofylline: Efficacy and safety in complex treatment of COPD
Tetyana Pertseva, Kateryna Gashynova, Natalia Klimenko

European Respiratory Journal Sep 2011, 38 (Suppl 55) p864;
Clinical efficacy and patients' satisfaction for 100 consequent COPD patients using tiotropium respimat
Motokazu Kato, Takashi Teranishi, Takehiko Kobayashi, Yumi Izuhara, Yuichi Higami, Yoshihiko Koshimo, Satoshi Marumo, Kohki Miura, Masahiro Kawashima

European Respiratory Journal Sep 2011, 38 (Suppl 55) p869;
Aclidinium bromide in patients with chronic obstructive pulmonary disease: Improvement in health status in ATTAIN
Paul W. Jones, Alvar Agusti, Eric D. Bateman, David Singh, Rosa Lamarca, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil

European Respiratory Journal Sep 2011, 38 (Suppl 55) p877;
The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD)
David Singh, Eric D. Bateman, Paul W. Jones, Alvar Agusti, Rosa Lamarca, Gonzalo de Miquel, Cynthia Caracta, Esther Garcia Gil

European Respiratory Journal Sep 2011, 38 (Suppl 55) p875;
NVA237 once daily provides rapid, clinically meaningful and sustained 24-h bronchodilation in patients with COPD: The GLOW1 trial
A. D'Urzo, G. Ferguson, M. Kato, S. Atis, C. Martin, V.K.T. Alagappan, D. Banerji, Y. Lu, T. Overend

European Respiratory Journal Sep 2011, 38 (Suppl 55) p866;
Assessments of protective effects of tiotropium bromide against methacholine- and neurokinin A-induced bronchoconstriction in patients with asthma
Eric Derom, Yannick Van Durme, Bihiyga Salhi, Christine Vander Stichele, Fre Bauters, Joyceline Sele, Roland Louis, Guy Joos

European Respiratory Journal Sep 2011, 38 (Suppl 55) p872;
The impact of tiotropium on mortality when added to inhaled corticosteroids and long-acting beta agonist therapy in COPD
Philip Short, Douglas Elder, Peter Williamson, Samuel Lipworth, Stuart Schembri, Brian Lipworth

European Respiratory Journal Sep 2011, 38 (Suppl 55) p871;
NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial
J.A. van Noord, K. Hirata, A. D'Urzo, C. Martin, R. Horton, Y. Lu, T. Overend

European Respiratory Journal Sep 2011, 38 (Suppl 55) p867;
Efficacy and safety of AZD3199, an inhaled ultra long-acting β₂-agonist, in patients with COPD
Piotr Kuna, Yavor Ivanov, Vasily Trofimov, Ola Beckman, Thomas Bengtsson, Carin Jorup, Francois Maltais

European Respiratory Journal Sep 2011, 38 (Suppl 55) p868;
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation, in COPD
Marc Decramer, Francois Maltais, Gregory Feldman, Jean Brooks, Lisa Willits, Stephanie Harris, Glenn Crater

European Respiratory Journal Sep 2011, 38 (Suppl 55) p878;

Main menu

User menu

Search

More articles from 96. Bronchodilators in asthma and COPD

Pages

Contact us